AbbVie is a global, research-based biopharmaceutical company. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.
Company Growth (employees)
Type
Public
HQ
North Chicago, US
Founded
2013
Size (employees)
30,000 (est)
Website
abbvie.com
AbbVie was founded in 2013 and is headquartered in North Chicago, US

Key People/Management at AbbVie

Richard A. Gonzalez

Richard A. Gonzalez

Chairman of the Board and Chief Executive Officer

AbbVie Office Locations

AbbVie has an office in North Chicago
North Chicago, US (HQ)
1 Waukegan Rd

AbbVie Financials and Metrics

AbbVie Financials

AbbVie's revenue was reported to be $25.6 b in FY, 2016
USD

Revenue (Q2, 2017)

6.9 b

Gross profit (Q2, 2017)

5.4 b

Gross profit margin (Q2, 2017), %

78%

Net income (Q2, 2017)

1.9 b

EBIT (Q2, 2017)

2.7 b

Market capitalization (08-Dec-2017)

153.8 b

Cash (30-Jun-2017)

6.1 b

EV

148.1 b
AbbVie's current market capitalization is $153.8 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

18.8 b20 b22.9 b25.6 b

Revenue growth, %

6%15%12%

Cost of goods sold

4.6 b4.4 b4.5 b5.8 b

Gross profit

14.2 b15.5 b18.4 b19.8 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

4.7 b4.6 b4.9 b5 b5 b5.5 b5.9 b6 b6.5 b6.4 b6.5 q6.9 b

Cost of goods sold

1.1 b1.1 b1.1 b1.1 b942 m916 m1.2 b1.4 b1.4 b1.5 b1.6 q1.5 b

Gross profit

3.6 b3.5 b3.8 b3.9 b4.1 b4.6 b4.8 b4.6 b5 b4.9 b4.9 q5.4 b

Gross profit Margin, %

77%76%77%78%81%83%80%77%78%77%75%78%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

9.6 b8.3 b8.4 b5.1 b

Accounts Receivable

3.9 b3.7 b4.7 b4.8 b

Inventories

1.2 b1.1 b1.7 b1.4 b

Current Assets

17.8 b16.1 b16.3 b16.2 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

9 b8.1 b9.1 b7.7 b7.9 b7.4 b9.2 b7.6 b6.3 b6.2 b4.7 b6.1 b

Accounts Receivable

3.8 b3.7 b3.7 b3.6 b4.2 b4.4 b4.6 b4.8 b5 b5 b4.7 b4.9 b

Inventories

1.2 b1.1 b1 b1 b1 b1.6 b1.8 b1.8 b1.8 b1.6 b1.4 b1.6 b

Current Assets

16.5 b17.3 b17.8 b17.6 b15.4 b16.9 b17.9 b16.6 b16.8 b16.3 b15.5 b17 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

4.1 b1.8 b5.1 b6 b

Accounts Receivable

681 m(172 m)(1.1 b)(71 m)

Inventories

(56 m)(203 m)(434 m)(38 m)

Accounts Payable

(426 m)(193 m)1.5 b(1.2 b)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

964 m980 m1.1 b2.6 b1 b2.4 b3.6 b1.4 b3 b4.6 b1.7 b3.6 b

Depreciation and Amortization

593 m158 m348 m575 m268 m557 m861 m374 m753 m

Accounts Receivable

81 m(194 m)(129 m)(34 m)(167 m)

Inventories

20 m(75 m)(160 m)(446 m)19 m(160 m)28 m71 m1 m
USDY, 2017

EV/EBIT

55.4 x

Revenue/Employee

231.5 k

Financial Leverage

11.1 x
Show all financial metrics

AbbVie Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Stem CentRxApril 28, 2016$5.8 b

AbbVie Market Value History

AbbVie Median Salaries

Source: 442 public H-1B filings from AbbVie

AbbVie's Web-traffic and Trends

AbbVie Online and Social Media Presence

AbbVie News and Updates

Activists press Alexion for stepped-up guidance, boardroom edits: report

Thanks to recent "turmoil" at the company, Leerink Partners analyst Geoffrey Porges has called Alexion “one of the rare, once or twice per decade, activist investment situations in the biopharmaceutical industry.” And one prominent activist reportedly wants to take advantage of the opportunity.

Biologics Market Healthcare and Clinical Analysis 2016 to 2027

The Analysis presents the study of Worldwide Biologicsfacilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold Posted via Industry Today. Follow us on Twitter @IndustryToday

In a crowded market, AbbVie may still have a best-in-class psoriasis prospect up its sleeve: analyst

The last few years have seen a wave of new biologics take the psoriasis market by storm. But a best-in-class product may still be on its way, one analyst says.

Salivary Gland Infection Market by Diagnosis - Plain Radiography & Sialography Type, Industry Outlook and Forecast till 2023

Global Salivary Gland Infection Market provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market Posted via Industry Today. Follow us on Twitter @IndustryToday

Endo scores a victory in its first testosterone bellwether case

Endo has been beset by a range of challenges, from generics pricing pressure to opioid lawsuits, but there was some good news this week in a lawsuit alleging wrongdoing in how it marketed its testosterone drug Testim.

Biopharmaceuticals 2017 AbbVie, Eli Lilly, Amgen, Merck, Johnson & Johnson Market Analysis And Forecast To 2022

Wiseguyreports.Com Adds “Biopharmaceuticals -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

AbbVie Company Life and Culture

You may also be interested in